MATINAS BIOPHARMA HOLDINGS, INC. Finance Lease, Right-of-Use Asset, after Accumulated Amortization
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $3.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2026-08-13
- 2026-06-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $3.00K.
- 2026-03-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $4.00K.
- 2025-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $4.00K.
- 2025-09-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $5.00K.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization | Finance Lease, Right-of-Use Asset, after Accumulated Amortization as first filed |
|---|---|---|
| 2026-06-30 | $3.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $4.00K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $4.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $5.00K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $6.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $7.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $8.00K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $17.00K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $18.00K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $20.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $21.00K 10-K · filed 2025-04-15 | |
| 2023-09-30 | $22.00K 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $24.00K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $25.00K 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $30.00K 10-K · filed 2024-03-27 | |
| 2022-09-30 | $7.03K 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $10.41K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $15.84K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $23.00K 10-K · filed 2023-03-15 | $22.27K 10-K · filed 2022-03-08 |
| 2021-09-30 | $28.71K 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $37.35K 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $45.99K 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $58.01K 10-K/A · filed 2022-03-11 | |
| 2020-09-30 | $66.65K 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $75.29K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $94.05K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $116.97K 10-K · filed 2021-03-29 | |
| 2019-09-30 | $141.97K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $166.98K 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $203.37K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |